Roche’s Columvi Meets Overall Survival Endpoint in Diffuse Large B-Cell Lymphoma Trial
Roche (SWX: RO), a leading Swiss pharmaceutical company, has announced that a late-stage clinical trial...
Novartis’s Fabhalta Shows Promise in Phase III IgA Nephropathy Trial
Swiss pharmaceutical giant Novartis (NYSE: NVS) has announced positive preliminary results from a Phase III...
EU Set to Investigate China’s Medical Device Procurement Practices Amid Fairness Concerns
The European Union (EU) is reportedly gearing up to launch an investigation into medical device...
Ningbo Menovo Partners with University of Michigan to Develop GLP-1 Delivery System
Ningbo Menovo Pharmaceutical Co., Ltd (SHA: 603538), a China-based company, has announced a strategic partnership...
Vazyme Partners with Yufang Medical to Boost Alzheimer’s Blood Test Sales Online
Vazyme Biotech Co., Ltd (SHA: 688105), based in China, has entered into a strategic partnership...
Keymed Biosciences Achieves First Dosing in Global Phase III Trial for Claudin 18.2 Targeting ADC
Keymed Biosciences Inc., (HKG: 2162), a biopharmaceutical company based in China, has announced the completion...
89bio Partners with BiBio Biopharma to Build API Facility for Pegozafermin in China
U.S. biotechnology company 89bio (NASDAQ: ETNB) has secured the services of China-based Contract Development and...
Shanghai Electric Group and Siemens Healthineers Unveil Ultramarine Series Medical Imaging Devices
Shanghai Electric Group, a major player in China’s electrical equipment industry, has partnered with Siemens...
JD Healthcare Forges Partnerships with Top Medical Device Firms at CMEF
The China International Medical Equipment Fair (CMEF), which took place last week in Shanghai, was...
FDA Advisory Committee Backs MRD as Accelerated Approval Endpoint for Multiple Myeloma
The Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) has...
I-Mab CEO Outlines Streamlined US Entity’s Focus and Potential for In-Licensing
I-Mab (NASDAQ: IMAB), a biopharmaceutical company that recently restructured into separate US and Chinese entities,...
Hainan Medical Zone Launches ‘Lecheng Global Special Medical Insurance’ for Wider Drug Access
The Hainan Boao Lecheng International Medical Tourism Pilot Zone has launched the “Lecheng Global Special...
Hengrui Pharmaceuticals Gets NMPA Approval for Clinical Study of CDK 4/6 Inhibitor Combo in Breast Cancer
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a prominent pharmaceutical company in China, has announced...
Blue Shield Biotech Faces Bankruptcy Proceedings After Missing Debt Payments
The Nanjing Qixia District People’s Court has accepted a bankruptcy liquidation case for Blue Shield...
Roche and Eli Lilly’s Elecsys pTau217 Blood Test Earns FDA Breakthrough Designation for Alzheimer’s Detection
The U.S. Food and Drug Administration (FDA) has granted a breakthrough device designation for Elecsys...
3SBio Secures NMPA Approval for Pediatric Thrombopoietin Treatment of ITP
3SBio Inc. (HKG: 1530), a leading biopharmaceutical company based in China, has announced that it...
Bayer Partners with Hologic to Develop Contrast-Enhanced Mammography Solution for Breast Cancer Diagnosis
Bayer (ETR: BAYN), a multinational pharmaceutical and life sciences company headquartered in Germany, has announced...
AbbVie’s Aquipta/Qulipta Shows Promise in Migraine Prevention Trial
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, last week released interim results from a...
Laekna’s Anti-ActRIIA Antibody LAE102 Clears FDA Hurdle for Obesity Treatment Trial
Sino-American biotech firm Laekna has announced that it has received clinical trial approval from the...
NHSA Reports 2023 Milestones in Basic Medical Insurance Participation and Financials
The National Healthcare Security Administration (NHSA) has published its annual “Healthcare Security Development Statistical Bulletin”...